Advances in novel induction therapies for patients with MM
3 November 2020 - 44 Minutes

Advances in novel induction therapies for patients with MM

Learning objective:

After participating in this broadcast you should be able to:

  • Discuss recent advances in novel induction therapies for patients with MM   

 

Scientific Committee and faculty:

  • Michel Delforge (Belgium)
  • Mohamad Mohty (France)

 

more info...

EM-40961
Genomic testing in CLL: why and how?
27 October 2020 - 51 Minutes

Genomic testing in CLL: why and how?

Join our expert faculty for this series of live, interactive broadcasts focusing on specific topics around the management of patients with chronic lymphocytic leukemia (CLL).

Have your questions and challenging cases addressed by the expert faculty by submitting your questions in advance or during each broadcast.

Below you will find the additional information and links to the broadcasts.
Pre–registration is required ...

more info...

EM-40959
ON-DEMAND webinar: What have we learnt about the use of cellular therapies in multiple myeloma?
27 October 2020 - 60 Minutes

ON-DEMAND webinar: What have we learnt about the use of cellular therapies in multiple myeloma?

This session will be broadcast live as part of the official ESH 5TH TRANSLATIONAL RESEARCH E-CONFERENCE : MULTIPLE MYELOMA program and will not be broadcast live on the HME Forum. It will be made available as an on-demand version here on the HME Forum after 27 October 2020. However, if you sign up in advance, we will update you as ...

more info...

EM-38739
ON-DEMAND webinar: A look into the future: How might we identify the most appropriate cellular therapy for patients with Multiple Myeloma?
27 October 2020 - 32 Minutes

ON-DEMAND webinar: A look into the future: How might we identify the most appropriate cellular therapy for patients with Multiple Myeloma?

This session will be broadcast live as part of the official HOPE 2020 program and will not be broadcast live on the HME Forum. It will be made available as an on-demand version here on the HME Forum after 27 October 2020. However, if you sign up in advance, we will update you as soon as the on-demand ...

more info...

EM-42884
What should we do for our patients with MM who relapse after lenalidomide therapy?
13 October 2020 - 49 Minutes

What should we do for our patients with MM who relapse after lenalidomide therapy?

Learning objective:

After participating in this broadcast you should be able to:

  • Review the available management options for patients with MM who relapse after lenalidomide therapy   

 

Scientific Committee:

  • Michel Delforge (Belgium)
  • Mohamad Mohty (France)

 

Faculty:

  • Mohamad Mohty (France)
  • María Victoria Mateos (Spain)
more info...

EM-40955
ON-DEMAND webinar: Multidisciplinary treatment approach in the management of patients with AL amyloidosis
7 October 2020 - 91 Minutes

ON-DEMAND webinar: Multidisciplinary treatment approach in the management of patients with AL amyloidosis

This session will be broadcast live as part of the official ISA 2020 program and will not be broadcast live on the HME Forum. It will be made available as an on-demand version here on the HME Forum after 7 October 2020. However, if you sign up in advance, we will update you as soon as the on-demand ...

more info...

EM-40442
ON-DEMAND webinar: An update on induction and front-line therapy for transplantation-eligible patients with multiple myeloma
7 September 2020 - 78 Minutes

ON-DEMAND webinar: An update on induction and front-line therapy for transplantation-eligible patients with multiple myeloma

This session will be broadcast live as part of the official EBMT 2020 program and will not be broadcast live on the HME Forum. It will be made available as an on-demand version here on the HME Forum after 7 September 2020. However, if you sign up in advance, we will update you as soon as the on-demand ...

more info...

EM-38433
Highlights from EHA 2020: A focus on chronic lymphocytic leukemia
18 June 2020 - 45 Minutes

Highlights from EHA 2020: A focus on chronic lymphocytic leukemia

Learning objective:

After participating in this broadcast you should be able to:

  • Evaluate how the data from EHA 2020 relating to chronic lymphocytic leukemia, B-cell lymphomas could potentially impact daily clinical practice  

 

Faculty:

  • John Gribben (UK)
  • Paolo Ghia (Italy)
  • Carol Moreno (Spain)

more info...

EM-33228
Highlights from EHA 2020: Expert insights and clinical implications for data on cell therapies in multiple myeloma
17 June 2020 - 46 Minutes

Highlights from EHA 2020: Expert insights and clinical implications for data on cell therapies in multiple myeloma

Learning objective:

After participating in this broadcast you should be able to:

  • Review the data presented EHA 2020 relating to the use of cell therapies in multiple myeloma

 

Faculty:

  • Michel Delforge (Belgium)
  • Paula Rodriguez (Spain)
  • Saad Usmani (USA)
more info...

EM-27215
Highlights from EHA 2020: Interpreting updates for your daily clinical practice in multiple myeloma
16 June 2020 - 49 Minutes

Highlights from EHA 2020: Interpreting updates for your daily clinical practice in multiple myeloma

Learning objective:

After participating in this broadcast you should be able to:

  • Evaluate how the data from EHA 2020 relating to multiple myeloma could potentially impact daily clinical practice

 

Faculty:

  • María Victoria Mateos (Spain)
  • Francesca Gay (Italy)
  • Katja Weisel (Germany)
more info...

EM-27207